ArcoScreen SA
Improving drug discovery through patient cell-screening.
ArcoScreen SA is an EPFL spin off founded in July 2021 in Lausanne. We are specialized in the development of tools for G protein coupled receptors (GPCRs) drug discovery. Our revolutionary technology enables the prediction of a drugs efficacy rapidly and early in the drug discovery process (lead optimization and mode of action identification) before expensive clinical trials directly on primary cells.
Our mission is to revolutionize drug discovery to improve patients lives.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
03.10.2023
First National Flagship Event 2023: Credit Suisse Investors and TOP 100 Startups connect over archery in Lausanne (venturelab.swiss)
25.05.2023
MassChallenge Switzerland 2023 Cohort is here ! (startupticker.ch)
16.12.2022
The 18 most promising biotech startups, according to investors (TOP 100)
12.10.2022
ArcoScreen and DAAV get FIT boost (startupticker.ch)
Last Tweets
15.12.2021
No Jobs
Videos
Deux chercheuses de l'EPFL ambitionnent de diminuer le taux d'échec lors du développement des médicaments contre Alzeihmer et Parkinson. Explication.
ArcoScreen: Screening patient cells improve drug discovery
Pitch Startup Champions Seed Night 2020
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Venture Leaders Medtech
ArcoScreen SA
Improving drug discovery through patient cell-screening.
Website:
www.arcoscreen.ch
Headquarter:
Lausanne
Foundation Date:
July 2021
Technology:
- Biotech
Sectors:
- Biotech
- Drug development platforms
- Drug discovery
- Micro technologies
- Research and development
Support received
